AstraZeneca PLC (NASDAQ:AZN)
| 67.92 Delayed Data As of 4:00pm ET |  +0.66 / +0.98%Today’s Change | 52.65 Today|||52-Week Range 72.12 | +0.18% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 67.26 |
| Today’s open | 67.73 |
| Day’s range | 67.09 - 68.00 |
| Volume | 327,344 |
| Average volume (3 months) | 4,831,164 |
| Market cap | $204.5B |
Data as of 4:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +2,588.61% |
| Earnings growth (this year) | +8.66% |
| Earnings growth (next 5 years) | +14.88% |
| Revenue growth (last year) | +17.23% |
| P/E ratio | 64.4 |
| Price/Sales | 4.77 |
| Price/Book | 5.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.21 | +0.52% |
| NVSNovartis | +1.07 | +1.30% |
| NVONovo Nordisk | +4.40 | +2.96% |
| MRKMerck | +0.60 | +0.58% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | April 28, 2023 |
| EPS forecast (this quarter) | $0.87 |
| Annual revenue (last year) | $44.4B |
| Annual profit (last year) | $3.3B |
| Net profit margin | 7.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
